The p53-Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53

Vinod Pant1, Shunbin Xiong, James G Jackson

  • 1Department of Genetics.

Genes & Development
|August 27, 2013
PubMed

Insights

The p53-Mdm2 feedback loop is crucial for regulating hematopoietic stem cell function after DNA damage. Disrupting this loop can sensitize stem cells, offering potential therapeutic strategies for blood cancers.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • The p53-Mdm2 feedback loop is thought to regulate p53 activity during cellular stress.
  • In vivo validation of this feedback loop's necessity has been lacking.

Purpose of the Study:

  • To investigate the in vivo role of the p53-Mdm2 feedback loop in regulating p53 activity and cellular responses to DNA damage.
  • To assess the physiological consequences of disrupting the p53-Mdm2 feedback loop.

Main Methods:

  • Generation of Mdm2(P2/P2) mice with mutated p53 response elements in the Mdm2 P2 promoter.
  • Analysis of p53 degradation kinetics and DNA damage response in various tissues, including hematopoietic stem cells (HSCs).

Main Results:

  • Mdm2(P2/P2) mice were viable and exhibited normal aging, indicating basal Mdm2 levels suffice for p53 regulation in most tissues.
  • Despite normal basal conditions, DNA damage induced an elevated p53 response in Mdm2(P2/P2) mice.
  • Enhanced p53-dependent apoptosis led to HSC sensitization, myeloablation, and lethality.

Conclusions:

  • The p53-Mdm2 feedback loop is essential for sustaining HSC function and managing p53 activity following DNA damage.
  • Targeting the p53-Mdm2 interaction may offer a therapeutic approach for hematological malignancies by affecting stem cells.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...